GENEMEDICS APP
GENEMEDICS NUTRITION
Recent data have implicated that melanocortin receptor agonists such as bremelanotide may play a role in modulating voluntary ethanol (alcohol) consumption, thereby treating alcohol addiction. In mice, melanocortin receptor agonist administration effectively reduces ethanol drinking, suggesting that it can be a potential therapeutic option for alcohol abuse disorders. [30-32]
Call 800-277-4041 for a Free Consultation